written by the physician that coordinated the patient’s treatment and would provide specific information on the timing and content of follow-up care, recommendations for prevention practices, and information about available psychosocial services, employment counseling, and access to health insurance.
“The transition from active treatment to survivorship care is critical to the long-term health and well being of people with cancer,” said Sandra J. Horning, MD, ASCO President and Co-Chair of ASCO’s Survivorship Task Force. “With more than 10 million cancer survivors living in the United States today, it is time to focus on all of the issues affecting these patients, both medical and psychosocial, so we can ensure they are getting the specialized attention they need.”
“One of the most important recommendations from the report is the need to develop a ‘Cancer Survivorship Care Plan’ for all survivors after their term of active treatment ends,” said Patricia A. Ganz, MD, co-chair of ASCO’s Survivorship Task Force and a member of the IOM committee that wrote the report. “Such a plan would allow oncology professionals and patients to work together to develop an individual care plan that summarizes the disease and treatment information patients need ensure high-quality, long-term medical care.”
Other discussions at the symposium will address building bridges between oncology and primary care providers; developing and testing models of survivorship care; guideline development and quality improvement; professional education and training; making better use of psychosocial and community support services and addressing employment and insurance issues; and clinical and health services research issues.
“Patient care does not end when the cancer treatment ends,” said NCCS President and two-time cancer survivor Ellen Stovall, who also is co-chair of the IOM committee that drafted the report. “Together, we can work to implement actively these recommendations from IOM, and to break down the barriers to ensuring quality, long-term care for cancer survivors.”
More than 100 stakeholders in the cancer community, including survivors, advocates, healthcare providers, government officials, insurers and payers, and researchers, will participate in the symposium discussion.
ASCO Survivorship Activities Related to IOM Recommendations
In addition to co-hosting the symposium, ASCO is undertaking a range of other activities to move the IOM recommendations forward, some of which are highlighted below. These are conducted under the direction of ASCO’s Survivorship Task Force, formed in December 2004 and co-chaired by Drs. Horning and Ganz. These efforts include:
Expert Panel: ASCO’s newly convened Survivorship Expert Panel is developing new evidence-based guidelines on the long-term medical care of adult cancer survivors. The overall purpose of the guideline is to provide health professionals with the knowledge and expertise to